Robotic Rehabilitation Gloves in the UK — Top 5 options for 2026
Published on Monday, 26 January 2026
Robotic rehabilitation gloves are wearable hand devices that use motors, soft robotics, sensors and software to assist recovery of hand and finger movement after injury or neurological conditions such as stroke. In the UK market they appeal to patients, carers and clinicians because they offer repeatable, intensive exercise, objective progress tracking and the potential for home-based therapy that complements clinic sessions. Consumers prioritise ease of use, clinical evidence, NHS compatibility or private service support, clear pricing and aftercare. Our curated guide for 2026 lists the top options that meet strict standards for clinical backing, UK support and regulatory compliance. At present this page shows Top 0 options because none met all of our inclusion criteria at the time of review. This may reflect evolving device approvals, manufacturer availability in the UK, or our rigorous selection filters designed to protect patients and purchasers.
Top Picks Summary
Neofect Rapael Smart Glove
Neofect's Rapael Smart Glove is a consumer-focused, sensor-driven rehabilitation glove that pairs motion-tracking with gamified exercises to support intensive at-home stroke and hand therapy. It holds a leading position for tele-rehabilitation and patient engagement because its app-driven model lowers per-session cost and administrative burden compared with clinic-bound systems, although it offers less heavy-duty mechanical assistance than industrial-grade exoskeletons. For programs prioritizing adherence, remote monitoring and cost-efficiency, Rapael is often the most practical choice in this list.
£1,200 – £2,500
Rehab-Robotics Gloreha Sinfonia
Gloreha Sinfonia from Rehab-Robotics is a clinical-grade robotic glove and exoskeleton designed for precise, multi-finger mobilization and therapist-led protocols, making it a market leader for hospital and rehab-center deployments. It distinguishes itself by delivering extensive passive and active training options and higher mechanical fidelity than wearable, low-profile alternatives, which justifies its higher acquisition and maintenance costs for clinics seeking comprehensive therapy capabilities. Compared with lighter consumer gloves on this list, Gloreha offers more deterministic, therapist-controllable interventions at the expense of portability and lower unit price.
Bioservo Carbonhand
Bioservo's Carbonhand is a soft-robotic, grip-assist device that augments finger flexion using lightweight textile actuators and proprietary soft exoskeleton technology to support activities of daily living. It stands out as the market leader for strength augmentation and long-duration assistive use—especially for neuromuscular weakness or industrial applications—because its durable construction and proven biomechanical assistance deliver measurable functional improvement that consumer rehab gloves typically do not. While less focused on gamified motor relearning than some competitors, Carbonhand offers superior assistance-for-use value and commercial maturity for patients needing ongoing grip support.
£7,000 – £12,000
syrebo Hand Rehabilitation Glove
syrebo's Hand Rehabilitation Glove emphasizes a lightweight, modular design with wearable sensors and real-time biofeedback to bridge the gap between clinic systems and home use; it is positioned as a cost-effective, clinician-friendly option for guided active-assist training. Its technical advantage lies in responsive assistance and customizable assistance profiles that can be tuned more aggressively than consumer-only apps, offering a middle ground between tele-rehab platforms like Neofect and heavy-duty clinical devices like Gloreha. For budgets that need more clinical control than app-only systems but cannot justify high-end exoskeleton spend, syrebo presents a balanced value proposition.
Rebless Robotic Rehabilitation Glove
The Rebless Robotic Rehabilitation Glove is an affordable, cable-driven rehabilitative glove aimed at scaling access to repetitive, assisted hand therapy in outpatient clinics and homes. Its primary market advantage is a lower unit price and simplified maintenance compared with premium exoskeletons, which makes it attractive for clinics and health systems seeking to expand therapy capacity economically, though it may offer fewer advanced sensors and less clinical validation than some market leaders. Rebless competes on accessibility and scalability, providing an inexpensive entry point into robot-assisted hand therapy for resource-conscious providers.
£800 – £1,800
What the research and clinical evidence say
Scientific studies and clinical reviews support the underlying principles of robotic-assisted hand therapy: repeated, task-specific movement, augmented feedback and adjustable assistance help drive neuroplasticity and functional gains. The evidence base includes randomized controlled trials and systematic reviews that show robotic training can improve arm and hand function when used alongside conventional therapy. Research also highlights important caveats: the size and quality of studies vary, outcomes depend on timing and intensity of treatment, and long-term cost-effectiveness in routine NHS pathways is still under evaluation.
Mechanism: Repetitive, guided movements and sensory feedback help retrain neural circuits involved in hand control, promoting functional recovery.
Clinical findings: Systematic reviews and randomized trials report modest to moderate improvements in hand strength, range of motion and task performance when robotic glove training is added to usual rehabilitation.
Safety and usability: Studies generally report good safety profiles; user comfort, fit and ease of donning/doffing are common determinants of daily use and adherence.
Remote and hybrid models: Early research supports the feasibility of telerehabilitation models using connected gloves for home practice with remote clinician supervision, increasing access for people outside major centres.
Limitations: Evidence quality is mixed, and larger pragmatic trials are needed to confirm which patient groups benefit most and to establish cost-effectiveness for widespread NHS adoption.
Frequently Asked Questions
Which robotic glove is best for home-based stroke recovery?
The Neofect Rapael Smart Glove is the ideal choice for home-based stroke recovery because it combines sensor-driven motion tracking with gamified exercises to keep patients engaged during intensive therapy sessions.
Does the Gloreha Sinfonia offer motorized multi-finger movement?
Yes, the Rehab-Robotics Gloreha Sinfonia features motorized multi-finger actuation that enables both passive and active-assisted movements for precise hand and wrist rehabilitation.
Is the Bioservo Carbonhand suitable for daily grip assistance?
The Bioservo Carbonhand is specifically designed for daily assistive use, utilizing lightweight carbon construction and tendon-driven actuators to amplify grip strength for those with neurological weakness or nerve injuries.
What is the user rating for the Neofect Rapael Smart Glove?
The Neofect Rapael Smart Glove holds an average rating of 4.4, reflecting its effectiveness for patients seeking cloud-connected, therapist-monitored rehabilitation at home.
Conclusion
Robotic rehabilitation gloves are a promising tool in UK neurorehabilitation, especially as devices become lighter, more connected and better supported by clinical services. We hope this guide helped explain the category and why no product currently appears in our Top 0 list under our review criteria. If you did not find what you were looking for, refine or expand your search criteria using the search box to include earlier-stage devices, international suppliers, or broader rehabilitation wearables.